An approach that’s bold
An approach that’s bold
An approach that’s bold
Driven by hope
Driven by hope
Driven by hope
Dedication that’s real
Dedication that’s real
Dedication that’s real

Innovative therapeutics that target
serious viral diseases

Assembly Bio is applying our passion, scientific ingenuity and deep knowledge of virology to pursue novel antivirals with the potential to change the paradigm for the treatment of serious diseases. Our ambitious and compassionate work has the potential to change lives.

Discover our pipeline
Scientific woman

Our two clinical candidates

for recurrent genital herpes are designed to address the serious consequences of this disease and provide significant innovation over current standard of care.

Learn more
rotating circle rotating circle

Our clinical candidates for chronic hepatitis D and chronic hepatitis B

aim to improve outcomes for individuals facing the significant burden associated with chronic infection.

Explore our programs

Passionate. Purpose driven. Patient focused.

Explore opportunities to join our team. We are collectively inspired by and committed to developing novel antivirals that improve the lives of people facing serious viral diseases.

Join us!
three scientific people
In the News
April 09, 2026
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026
March 19, 2026
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights
December 22, 2025
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
    rotating circle rotating circle